By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Constellation Pharmaceuticals 

215 First St, Suite 200

Cambridge  Massachusetts  02142  U.S.A.
Phone: 617-714-0555 Fax: 617-859-2891


SEARCH JOBS



Key Statistics


Email:
Ownership: Private

Web Site: Constellation Pharmaceuticals
Employees:
Symbol: 
 




Segment
Start Up





Company News
Constellation Pharmaceuticals and the University of Pittsburgh School of Medicine Receive Cystic Fibrosis Foundation Research Grant 10/10/2013 9:36:10 AM
Constellation Pharmaceuticals Announces New Preclinical Data on Novel BET Bromodomain Inhibitors Published in The Journal of Experimental Medicine 10/8/2013 10:38:19 AM
Constellation Pharmaceuticals Initiates Clinical Development of CPI-0610, a Novel BET Protein Bromodomain Inhibitor, in Patients With Lymphoma 9/10/2013 9:32:50 AM
Constellation Pharmaceuticals and The Leukemia & Lymphoma Society Partner to Develop Novel BET Inhibitor for the Treatment of Hematologic Malignancies 9/20/2012 10:22:54 AM
Constellation Pharmaceuticals Appoints Keith E. Dionne, Ph.D., as Chief Executive Officer 3/27/2012 6:52:54 AM
Genentech (RHHBY) Pours $95 Million into Constellation Pharmaceuticals Epigenetic Drug Platform, Deal Includes M&A Terms 1/17/2012 6:55:55 AM
Constellation Pharmaceuticals Raises $15 Million in Additional Funding 6/6/2011 6:34:59 AM
Constellation Pharmaceuticals Expands Leadership Team with Drug Development Industry Veterans 2/1/2011 8:44:14 AM
Constellation Pharmaceuticals Appoints Industry Veteran James E. Audia, Ph.D. as Chief Scientific Officer 1/4/2011 8:58:18 AM
Constellation Pharmaceuticals Closes $22 Million in Series B Funding 6/2/2010 6:32:11 AM
12
//-->